Altman Michael Seth
Nautilus Biotechnology, Inc. · Director
Altman Michael Seth is listed in public filings as director. This Altman Michael Seth insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Nautilus Biotechnology, Inc. (NAUT), and Lyra Therapeutics, Inc. (LYRA). Investors use Altman Michael Seth's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $115k45k shares | Grant / ExerciseJun 14, 2024 | $115.2K45k shares | $2.56 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $9.3k30k shares | Grant / ExerciseJun 13, 2024 | $9.3K30k shares | $0.31 | -- |